Gastrointestinal safety and efficacy of long-term GCSB-5 use in patients with osteoarthritis: A 24-week, multicenter study
Conclusions The safety and efficacy profile of GCSB-5 are comparable to celecoxib. These results indicate GCSB-5 is safe for a long-term treatment of knee OA patients. Trial registration ClinicalTrials.gov (NCT01604239). Graphical abstract
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Arthritis | Bleeding | Celebrex | Drugs & Pharmacology | Gastroenterology | Osteoarthritis | Pain | Rheumatology | Study